Astera Labs: Substantial Beat and Raise Before Product Cycle Fully Accelerates

Core Thesis

Astera Labs delivered its eighth consecutive beat-and-raise quarter, guiding JuneQ revenue to $360 million versus consensus of $310 million—16% above expectations and representing roughly 6x the quarterly run rate since IPO eight quarters ago. The Scorpio product family is the primary growth engine and remains in an early ramp phase, with management explicitly stating "a significant leg of growth ahead." Dollar content per XPU now exceeds $1,000 and continues to trend higher. Optical products (NPO/CPO) beginning in 2027, KV cache offload design wins, custom solutions, and CXL-based Leo will expand the addressable market further. With high-30s operating margins and active fund ownership at only 59.8%, the stock has room for multiple expansion as estimates rise.

Market Mispricing: Underappreciated Duration and Breadth of the Scorpio Cycle and Adjacent TAM

The consensus has underestimated both the longevity of the Scorpio ramp and the incremental TAM from products still to reach production. The current guidance implies merely 17% sequential growth, yet the product cycle is early: higher-radix switch configurations are only beginning to penetrate hyperscaler deployments. Optical (NPO/CPO) contributions, expected in 2027-2028, have no revenue in current models, nor do KV cache offload, CXL, or UAL-based designs. Investors are pricing only the visible beat-and-raise momentum without embedding the compound growth from multiple future catalysts. At 59.8% active ownership, positioning remains cold relative to the fundamental acceleration trajectory.

Evidence Chain

Scorpio is the near-term growth driver and still early in its ramp.

• JuneQ revenue guidance midpoint of $360 million (+17% qoq, +88% yoy) was $50 million above the Street estimate of $310 million.
• Management described the Scorpio ramp as "still in its early stages, with a significant leg of growth ahead."

Content per accelerator is rising and supports system-level value expansion.

• Dollar content per XPU now exceeds $1,000 per accelerator and is trending higher.
• High-radix switch configurations are driving increased connectivity value per system, directly tied to Scorpio adoption.

Next-generation products will expand the TAM in 2027 and beyond.

• Optical solutions (NPO/CPO) are expected to begin ramping in 2027; Astera has invested organically for several years rather than relying on acquisitions.
• KV cache offload has already secured design wins, and CXL-based memory expansion (Leo) and custom solutions (e.g., NVLink Fusion) are advancing.
• Deep hyperscaler relationships position Astera to compete in UAL-based architectures.

Key Risks

• Competitive displacement in Aries retimers: Aries faces potential share loss as alternative retimer solutions emerge, which could compress margins and growth rates in the legacy product line.
• AI capital expenditure cyclicality: A pause or reallocation in hyperscaler data center investment would directly reduce demand for Scorpio and future products.
• Next-generation technology delays: CXL 1.6T ports, optical interconnect, and UAL timelines may slip, pushing revenue contributions further into 2028 or beyond.

Valuation and Trade Implication

Maintain Overweight rating; increase price target to $240 (from $210). The target is derived using 0.53x EV/Sales/Growth on a 2026-2028 revenue CAGR of 40%, implying roughly 21x EV/Sales on 2027 revenue. This multiple is justified by Astera’s 80% year-over-year top-line growth in FY2026, operating margins approaching 40% (non-GAAP), and a product cycle that runs multiple years beyond current consensus projections. The revision in estimates—2026 revenue growth raised from 54% to 80%, and FY2026 non-GAAP EPS from $2.29 to $2.88—creates a path for further upside as the market reprices the duration of this growth. With only 59.8% active ownership, fund rotation into the name is likely to continue supporting the stock.

Appendix Data Summary